| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $683.2M | +26.3% |
| Cost of Revenue | $154.8M | +45.5% |
| Gross Profit | $528.4M | +21.5% |
| R&D Expense | $143.6M | +23.3% |
| SG&A Expense | $103.2M | +14.8% |
| Operating Income | -$67.8M | -62.4% |
| Interest Expense | $19.0M | +153.3% |
| Income Tax | $6.9M | +275.4% |
| Net Income | -$92.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $300.9M | +8.2% |
| Short-term Investments | $266.6M | +13.8% |
| Accounts Receivable | $187.3M | +37.1% |
| Current Assets | $857.2M | +14.4% |
| Total Assets | $1.44B | +15.3% |
| Current Liabilities | $584.2M | +20.7% |
| Total Liabilities | $1.17B | +13.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $131.2M | +35.5% |
| Capital Expenditures | $9.4M | +42.6% |
| Investing Cash Flow | -$128.0M | +67.3% |
| Financing Cash Flow | $23.3M | -94.1% |
| Free Cash Flow | $121.8M | +35.0% |
| -97.6% |
| EPS (Basic) | -$0.83 | -88.6% |
| EPS (Diluted) | -$0.83 | -88.6% |
| Stockholders' Equity |
| $270.9M |
| +25.8% |